Search Within

Li-Xuan Qin

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Journal Article (4)
  2. Meeting Abstract (3)
Groups
  1. Biostatistics Service (7)
  2. CTCR Scholars (7)
  3. Department of Pathology and Laboratory Medicine (7)
  4. Epidemiology and Biostatistics (7)
  5. GSK Faculty (7)
  6. MSK Grad Students (7)

More Groups

People
  1. Edmund Bartlett (7)
  2. Samuel Singer (7)
  3. Aimee Crago (6)
  4. Cristina Antonescu (5)
  5. Ping Chi (5)
  6. Ciara Kelly (4)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (1)
  4. 2021 (1)
  5. 2020 (1)
Publications
  1. Annals of Oncology (1)
  2. Annals of Surgery (1)
  3. Annals of Surgical Oncology (1)
  4. Clinical Cancer Research (1)
  5. JAMA Oncology (1)
  6. JCO Precision Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (2)
  2. American Association for Cancer Research (1)
  3. American Medical Association (1)
  4. Lippincott Williams & Wilkins (1)
  5. Oxford University Press (1)
  6. Springer (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Kelly, C. M.; Bradic, M.; Saunds, S.; Avutu, V.; Chan, J.; D'Angelo, S. P.; Dickson, M.; Gounder, M.; Keohan, M. L.; Movva, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Histologic subvariant predicts outcome in primary retroperitoneal well- differentiated liposarcoma
    Meeting Abstract

    Li, G. Z.; Lee, J.; Whiting, K. A.; Qin, L. X.; Bartlett, E. K.; Crago, A. M.; Brennan, M.; Hameed, M. R.; Singer, S.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Journal Article

    Kelly, C. M.; Qin, L. X.; Whiting, K. A.; Richards, A. L.; Avutu, V.; Chan, J. E.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Histology-specific prognostication for radiation-associated soft tissue sarcoma
    Journal Article

    Bartlett, E. K.; Sharma, A.; Seier, K.; Antonescu, C. R.; Agaram, N. P.; Jadeja, B.; Rosenbaum, E.; Chi, P.; Brennan, M. F.; Qin, L. X.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Histologic subtype defines the risk and kinetics of recurrence and death for primary extremity/truncal liposarcoma
    Journal Article

    Bartlett, E. K.; Curtin, C. E.; Seier, K.; Qin, L. X.; Hameed, M.; Yoon, S. S.; Crago, A. M.; Brennan, M. F.; Singer, S.
    Annals of Surgery (2021)

    Fulltext@MSK | Save
  • Objective response rate among patients with locally advanced or metastatic sarcoma treated with talimogene laherparepvec in combination with pembrolizumab: A phase 2 clinical trial
    Journal Article

    Kelly, C. M.; Antonescu, C. R.; Bowler, T.; Munhoz, R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Dholakia, R.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save